![Steven Pieper](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Steven Pieper
Finanzdirektor/CFO bei
XERIS BIOPHARMA HOLDINGS, INC.
Vermögen: 6 Mio $ am 31.05.2026
Profil
Steven M.
Pieper is currently Chief Financial Officer at Xeris Biopharma Holdings, Inc. since 2021.
Formerly, Mr. Pieper was Finance Director at Durata Therapeutics, Inc., Chief Financial & Accounting Officer at Xeris Pharmaceuticals, Inc. in 2021, and Chief Operating & Financial Officer at Catheter Connections, Inc. from 2015 to 2017.
Education includes an undergraduate degree from DePaul University and an MBA from Loyola University of Chicago.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 14.04.2026 | 980’621 ( 0.57% ) | 6 Mio $ | 31.05.2026 |
Aktive Positionen von Steven Pieper
| Unternehmen | Position | Beginn |
|---|---|---|
| XERIS BIOPHARMA HOLDINGS, INC. | Finanzdirektor/CFO | 01.10.2021 |
Ehemalige bekannte Positionen von Steven Pieper
| Unternehmen | Position | Ende |
|---|---|---|
Catheter Connections, Inc.
 Catheter Connections, Inc. Medical SpecialtiesHealth Technology Develops vascular access products | Finanzdirektor/CFO | 01.01.2017 |
| DURATA THERAPEUTICS INC | Finanzdirektor/CFO | 01.11.2014 |
Xeris Pharmaceuticals, Inc.
 Xeris Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes ready-to-use and liquid-stable injectables | Finanzdirektor/CFO | - |
Ausbildung von Steven Pieper
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
4
Beziehungen ersten Grades
6
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
Xeris Pharmaceuticals, Inc.
Xeris Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes ready-to-use and liquid-stable injectables | Health Technology |
Catheter Connections, Inc.
Catheter Connections, Inc. Medical SpecialtiesHealth Technology Develops vascular access products | Health Technology |
DePaul University
 DePaul University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Loyola University of Chicago
 Loyola University of Chicago Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Durata Therapeutics, Inc.
 Durata Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel therapeutics for infectious diseases and acute illnesses | Health Technology |
Xeris Biopharma Holdings, Inc.
 Xeris Biopharma Holdings, Inc. BiotechnologyHealth Technology Develops and commercializes therapies | Health Technology |
